University of Barcelona identifies ENT1 protein as potential treatment target for fatty liver disease
Researchers at the University of Barcelona have discovered that the protein ENT1, which transports small molecules, plays a key role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD), the world's most common chronic liver disease. The finding could lead to new treatment approaches for the condition.
